Publications

Patient-Reported Outcomes from Destiny-Breast04: Trastuzumab Deruxtecan Versus Physician's Choice of Chemotherapy in Patients with Her2-Low Mbc

AuthID
P-018-SYT

Author(s)

Ueno, NT

Cottone, F

Dunton, K

Jacot, W

Yamashita, T

Sohn, J

Tokunaga, E

Prat, A

Tsurutani, J

Park, YH

Rugo, HS

Xu, BH

Cardoso, F

Mitri, Z

Mahtani, R

Aguilar, CO

Xiao, F

Harbeck, N

Cameron, DA

Modi, S

Document Type

Article

Year published

2025

Published

in ONCOLOGIST, ISSN: 1083-7159

Volume: 30, Issue: 5

Indexing

Wos^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1093/oncolo/oyaf048

Pubmed: 40349139

Wos: WOS:001484953200006

Source Identifiers

ISSN: 1083-7159

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Patient-Reported Outcomes from Destiny-Breast04: Trastuzumab Deruxtecan Versus Physician's Choice of Chemotherapy in Patients with Her2-Low Mbc

Useful Links

Get Help

Federated Authentication (Click on the image)

Patient-Reported Outcomes from Destiny-Breast04: Trastuzumab Deruxtecan Versus Physician's Choice of Chemotherapy in Patients with Her2-Low Mbc

Useful Links

Get Help